Michael Doney, MD, MPH, MS
Executive Medical Director shaping Biograph's clinical model, with genomics, metabolomics, CDC, Human Longevity, and Color experience
At a glance
- Years in practice
- 27
Practice
About
Michael Doney is Biograph's Executive Medical Director, the physician shaping the clinical methodology across the New York and San Francisco Bay Area clinics. His path into precision preventive medicine runs through emergency medicine training at UC San Diego, four years at the U.S. CDC, and Director of Medical Affairs roles at Human Longevity and Color. He also holds an MS in molecular genetics from Cincinnati and an MPH in Global Health Policy from George Washington University, which fits Biograph's work of reading genome, metabolomic, imaging, and cardiometabolic data together.
Reviews
Approach
Signature approach
Doney's work is about interpretation: turning genome, metabolomic, imaging, and biomarker data into a coherent prevention model. His emergency-medicine, CDC, and genomics-company background gives the methodology a practical throughline, from urgent clinical pattern recognition to population health to individual decision support.
What sets them apart
- Published in Biograph's core methodology. He co-authored a 2020 PNAS paper combining whole-genome sequencing, metabolomics, and advanced imaging.
- Genomics-native training path. His MS in molecular genetics and medical-affairs roles at Human Longevity and Color place him closer to precision diagnostics than the usual functional-medicine or endocrinology route.
- Clinical-research platform. He is principal investigator on Biograph's Caristo Diagnostics AI cardiac-risk study and has spoken publicly through the WSJ Leadership Institute on longevity predictors.
Focus
Specialties
Who they see
Conditions treated
- I'm worried about early signs of heart diseaseSubclinical atherosclerosis
- My cholesterol and metabolic numbers are offDyslipidemia and cardiometabolic syndrome
- I want to catch cancer risk earlyOncologic screening and risk stratification
- I want to protect my brain from cognitive declineNeurodegenerative disease risk assessment
- I've had unexplained weight gain or my metabolism has slowedMetabolic dysfunction
- I have a family history of chronic diseaseHereditary risk assessment via genomic analysis
Training
Education
- MDUniversity of Cincinnati College of Medicine (1999)
- MPH, Global Health PolicyGeorge Washington University
- MS, Molecular GeneticsUniversity of Cincinnati College of Medicine
- Internal MedicineUniversity of California San Diego Medical Center (1999–2000)
Residency
- Emergency MedicineUniversity of California San Diego Medical Center (2000–2003)
- NPI
- 1942366604
Protocols
- Whole genome sequencing
- Comprehensive metabolomics
- Dexa body composition
- Full Body mri
- Coronary ct angiography (ccta)
- Ai Powered cardiac risk analysis (caristo cari Heart)
- Advanced blood biomarker panels
- Vo2 max testing
- Continuous glucose monitoring
- Digital health platforms and decision support tools
Elsewhere
Media and talks
- Fitt Insider · 2025-05
- Haute Living · 2026-04
- The Metabolic Link
Profiles
Before You Book
- Expect site-based care. Doney sets the network methodology. San Mateo visits route through Gilberto Hernandez, MD, PhD; New York visits route through Jim Lebret, MD or Yihan Chen, MD, MPH.
- His lens shows up in the protocols. Cardiometabolic, neurodegenerative, genomic, and imaging interpretation are built into the Biograph assessment model.
- Choose by clinic access. For booking, the practical choice is San Mateo versus New York; Doney's role sits behind both clinics.
Verification
- Profile updated
- Credentials checked
Primary sourcehttps://www.biograph.com/about/people/dr-michael-doney
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.